Health
Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model – News-Medical.Net
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
Using a combination of personal passion and expertise, Klauber-DeMore…
Continue Reading
-
Noosa News24 hours agoThe only person detained at Brisbane’s Palestine rally
-
Business23 hours agoHow to turn $500 a month into $500,000 with ASX shares
-
General16 hours agoAustralia urged to give AUKUS sub ‘commitments’ to US in event of war
-
Noosa News21 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools